Skip to main content

Incident Use of Testosterone Products Among All Members and Members with Pre-Existing Testosterone Use

Basic Details
Date Posted
Status
Complete
Medical Product
Androgel
Axiron
Fortesta
intramuscular testosterone
methyltestosterone
Striant
Testim
testosterone
testosterone cypionate
testosterone enanthate
testosterone pellet
testosterone propionate
testosterone suspension
transdermal testosterone
Description

Modular program-based one-time assessment of the incident use of testosterone products among members with pre-existing testosterone use and members with no pre-existing inclusions or exclusions. The query was run against the Mini-Sentinel Distributed Database (MSDD) for the time period of January 1, 2007 to May 31, 2013. Modular programs are adaptable standardized programs. Results were generated using Modular Program 3, version 1.0; click here for more information.  Queries were distributed in March 2014. This report includes data from 18 Data Partners.
 
If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by sending an email requesting assistance to info@sentinelsystem.org.
 
The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

Deliverables (1)
Mini-Sentinel Modular Program Report: Incident use of Testosterone Products among All Members and Members with Pre-Existing Testosterone Use
Additional Details
FDA Center
CDER
Time Period
January 1, 2007 - May 31, 2013
Analysis Type
Mini-Sentinel
Population / Cohort
All individuals with pre-existing testosterone use
Data Sources
Mini-Sentinel Distributed Database (MSDD)